8-KEarnings & ResultsExhibits & Filings

CVS HEALTH Corp 8-K Report, Financial Results (Aug 7, 2012)

Filed August 7, 2012For Securities:CVS

Summary

CVS Health Corporation (CVS) filed a Form 8-K on August 7, 2012, to report its earnings for the three months ended June 30, 2012. The filing primarily serves to attach the earnings press release dated August 7, 2012, as Exhibit 99.1. Investors should refer to this press release for detailed financial results and operational performance. This report itself does not contain specific financial figures but indicates that the company's performance for the second quarter of 2012 was communicated to the public via the attached press release. The filing also confirms the Chief Financial Officer, David M. Denton, signed off on the report, affirming the authenticity of the provided information.

Key Highlights

  • 1CVS Health Corporation (CVS) filed an 8-K on August 7, 2012.
  • 2The primary purpose of the filing is to disclose the company's financial results for the second quarter of 2012 (ended June 30, 2012).
  • 3Exhibit 99.1 contains the earnings press release dated August 7, 2012, which holds the detailed financial information.
  • 4The information furnished is not considered 'filed' for the purposes of SEC registration statements unless specifically incorporated by reference.
  • 5The filing was signed by David M. Denton, Executive Vice President and Chief Financial Officer.
  • 6This 8-K serves as notification and public dissemination of Q2 2012 earnings performance.
  • 7Investors seeking specific Q2 2012 financial data (revenue, profit, etc.) must consult the referenced press release (Exhibit 99.1).

Frequently Asked Questions

The main purpose of this 8-K filing by CVS Health Corporation is to publicly announce and provide investors with the company's earnings results for the second quarter ended June 30, 2012, by attaching the relevant press release.

The specific financial details for the second quarter of 2012 are contained within the press release dated August 7, 2012, which is attached as Exhibit 99.1 to this Form 8-K filing.

This Form 8-K itself does not contain forward-looking statements or guidance. Such information would typically be found within the attached earnings press release (Exhibit 99.1) or subsequent filings.

This report was signed by David M. Denton, who held the position of Executive Vice President and Chief Financial Officer at CVS Health Corporation at the time of the filing.